...
首页> 外文期刊>The international journal of biochemistry and cell biology >Brain microvascular endothelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis
【24h】

Brain microvascular endothelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis

机译:脑微血管内皮诱导的annexin A1分泌促进小细胞肺癌脑转移

获取原文
获取原文并翻译 | 示例
           

摘要

Small cell lung cancer is the most aggressive histologic subtype of lung cancer, with a strong predilection for metastasizing to brain early. However, the cellular and molecular basis is poorly known. Here, we provided evidence to reveal the role of annexin A1 in small cell lung cancer metastasis to brain. Firstly, the elevated annexin A1 serum levels in small cell lung cancer patients were associated with brain metastasis. The levels of annexin A1 were also upregulated in NCI-H446 cells, a small cell lung cancer cell line, upon migration into the mice brain. More interestingly, annexin A1 was secreted by NCI-H446 cells in a time-dependent manner when co-culturing with human brain microvascular endothelial cells, which was identified with the detections of annexin A1 in the co-cultured cellular supernatants by ELISA and western blot. Further results showed that blockage of annexin A1 in the co-cultured cellular supernatants using a neutralized antibody significantly inhibited NCI-H446 cells adhesion to brain endothelium and its transendothelial migration. Conversely, the addition of Ac2-26, an annexin A1 mimic peptide, enhanced these effects. Furthermore, knockdown of annexin A1 in NCI-H446 cells prevented its transendothelial migration in vitro and metastasis to mice brain in vivo. Our data showed that small cell lung cancer cell in brain microvasculature microenvironment could express much more annexin A1 and release it outside, which facilitated small cell lung cancer cell to gain malignant properties of entry into brain. These findings provided a potential target for the management of SCLC brain metastasis. (C) 2015 Elsevier Ltd. All rights reserved.
机译:小细胞肺癌是肺癌中最具侵略性的组织学亚型,非常倾向于早期转移到大脑。但是,细胞和分子基础知之甚少。在这里,我们提供了证据揭示膜联蛋白A1在小细胞肺癌转移至脑中的作用。首先,小细胞肺癌患者血清膜联蛋白A1水平升高与脑转移有关。迁移到小鼠脑中后,NCI-H446细胞(一种小细胞肺癌细胞系)中膜联蛋白A1的水平也上调。更有趣的是,与人脑微血管内皮细胞共培养时,NCI-H446细胞以时间依赖性方式分泌膜联蛋白A1,这可以通过ELISA和Western blot在共培养的细胞上清液中检测到膜联蛋白A1来鉴定。 。进一步的结果表明,使用中和抗体对共培养的细胞上清液中膜联蛋白A1的阻断显着抑制了NCI-H446细胞对脑内皮细胞的粘附及其跨内皮迁移。相反,添加膜联蛋白A1模拟肽Ac2-26增强了这些作用。此外,在NCI-H446细胞中,膜联蛋白A1的敲低阻止了膜联蛋白A1在体外的跨内皮迁移和体内转移到小鼠脑中。我们的数据表明,脑微血管微环境中的小细胞肺癌细胞可以表达更多的膜联蛋白A1并释放到外界,这促进了小细胞肺癌细胞获得进入脑部的恶性特性。这些发现为SCLC脑转移的治疗提供了潜在的目标。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号